Drug Trial Radar · NCT02181413
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant
Last checked: Nov 20, 2026Latest source record: Nov 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
656
Actual
Start
Jul 16, 2014
Primary completion
Apr 16, 2018
Study completion Sep 8, 2023
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Jul 4, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effect of ixazomib citrate maintenance therapy on progression-free survival (PFS), compared to placebo, in participants with newly diagnosed multiple myeloma (NDMM) who have had a response (complete response \[CR\], very good partial response \[VGPR\], or partial response \[PR\]) to induction therapy followed by high-dose therapy (HDT) and autologous stem cell transplant (ASCT).
Conditions
- Multiple Myeloma
- Autologous Stem Cell Transplant
Interventions
Ixazomib CitrateDrug
Ixazomib citrate capsules
PlaceboDrug
Ixazomib citrate placebo-matching capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS)Time frame: Randomization up to End of treatment (EOT) (24 months); thereafter followed up every 4 weeks (up to 45 months)
Locations
227 sites in 33 countries. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Mayo Clinic - PPDS
Rochester, Minnesota
Montefiore Medical Center
The Bronx, New York
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
Baylor University Medical Center
Dallas, Texas
West Virginia University Hospital
Morgantown, West Virginia
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Hospital Iturraspe
Santa Fe, Argentina
Hospital Italiano de La Plata
La Plata, Buenos Aires, Argentina
Instituto de Hematologia Y Medicina Clinica Dr Ruben Davoli
Rosario, Santa Fe Province, Argentina
Sanatorio Britanico de Rosario
Rosario, Santa Fe Province, Argentina
Sanatorio Parque de Rosario
Rosario, Santa Fe Province, Argentina
St George Hospital
Kogarah, New South Wales, Australia
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Icon Cancer Care South Brisbane
South Brisbane, Queensland, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
The Queen Elizabeth Hospital
Woodville South, South Australia, Australia
Austin Health
Heidelberg, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Elisabethinen Hospital Linz
Linz, Austria
Salzburger Landeskliniken
Salzburg, Austria
Allgemeines Krankenhaus der Stadt Wien
Vienna, Austria
Klinik Ottakring (fruher: Wilhelminenspital)
Vienna, Austria
ZNA Middelheim
Antwerp, Belgium
ZNA Stuivenberg
Antwerp, Belgium
Centre Hospitalier Jolimont-Lobbes
La Louvière, Hainaut, Belgium
Centre Hospitalier Universitaire Ambroise Pare
Mons, Hainaut, Belgium
UZ Gent
Ghent, Oost-Vlaanderen, Belgium
AZ Sint-Jan AV
Bruges, West-Vlaanderen, Belgium
Instituto Nacional de Cancer
Rio de Janeiro, Brazil
Universidade Federal do Rio de Janeiro - UFRJ
Rio de Janeiro, Brazil
Irmandade Da Santa Casa de Misericordia de Sao Paulo
São Paulo, Brazil
Hospital Israelita Albert Einstein
São Paulo, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil
Hospital Das Clinicas Da Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Instituto de Oncologia Do Parana
Curitiba, Paraná, Brazil
Liga Paranaense de Combate Ao Cancer - Hospital Erasto Gaertner
Curitiba, Paraná, Brazil
Hospital de Clinicas de Passo Fundo
Passo Fundo, Rio Grande do Sul, Brazil
Showing 40 of 227 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.